查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1447150

到 2030 年经皮给药系统市场预测：按产品类型、组件、技术、应用、最终用户和地区进行的全球分析

Transdermal Drug Delivery Systems Market Forecasts to 2030 - Global Analysis By Product Type (Transdermal Patches, Gels, Sprays, Microneedles, Iontophoresis Systems & Other Product Types), Component, Technology, Application, End User & By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2023年全球经皮给药系统市场规模将达662亿美元，预计2030年将达到1,646亿美元，预测期内复合年增长率为13.9%。

经经皮给药系统透过皮肤给药，提供一种非侵入性和受控的方法。经经皮给药系统利用含有缓慢吸收到血流中的药物製剂的贴片。皮肤的外层角质层可作为屏障并调节药物释放。这种方法可以最大限度地减少副作用，提高患者的依从性并稳定药物浓度。

根据世界神经病学联合会2023年报告，神经系统疾病现已成为全球第二大死因和第一大残疾原因。全球疾病负担 (GBD) 研究预测，到 2050 年，患有脑部疾病的人数将增加一倍。

慢性病增加

随着糖尿病、心血管疾病和慢性疼痛的流行，TDDS 因其方便性、药物缓释和提高患者依从性而成为首选解决方案。随着长期用药需求的不断增加，TDDS 可以实现非侵入性且使用者友好的给药方式。这一趋势正在推动市场成长，推动药物创新，扩大经皮吸收贴片的治疗范围，并为有效的慢性病管理创造一个充满活力的前景。

合适的药物有限

某些药物的固有特性，例如分子大小、亲油性和电荷，限制了有效的经皮给药。这项限制缩小了应用范围并阻碍了市场成长。製药业的进步对于增加与 TDDS 相容的药物种类至关重要。克服这一限制对于充分发挥经皮给药的潜力以提供一种非侵入性且对患者友好的替代方案至关重要，特别是对于对慢性病管理至关重要的药物至关重要。

对非侵入性药物输送的需求不断增长

随着患者寻求方便且无痛的替代方案，经皮吸收贴片透过皮肤输送药物提供了一种有吸引力的解决方案。这种方法提高了患者的依从性和舒适度，特别是对于需要长期治疗的慢性病。经经皮给药对于满足医疗保健需求非常重要，因为人们对非侵入性选择的偏好不断增加，减少与针头相关的焦虑并改善整体治疗体验的愿望推动了他被定位为一个强大的参与者。

开发和监管成本高

复杂而严格的监管要求，加上庞大的研发成本，为公司带来了经济障碍。这些成本会抑制投资和创新，并限制新的经皮製剂的推出。因此，市场成长可能会放缓，先进经皮製剂技术的取得可能会减少。

COVID-19 的影响

供应链中断、医疗就诊减少以及对抗疫情的资源转移正在影响市场成长。然而，对非侵入性药物传递方法的需求以及对家庭治疗的关注导致人们对经皮系统的兴趣增加。该行业正在适应应对远端患者监测和提高经皮功效等挑战。这场流行病加速了该领域的创新和研究，随着医疗保健需求和偏好的变化，增强了韧性和未来的成长潜力。

在预测期内，经皮贴片製剂领域预计将是最大的。

由于易于使用、副作用减少以及贴片相关合规性的提高，经皮贴片正在推动市场成长。经皮吸收贴片具有控制药物释放、持续治疗水准和最小化变异性等优点。这导致患者和医疗保健提供者的接受度提高。此外，随着技术进步解决挑战并为创新应用铺平道路，以及标誌着向更高效和以患者为中心的药物输送解决方案的持续转变，经皮药物输送系统市场必将扩大。

预计疼痛管理产业在预测期内复合年增长率最高

预计疼痛管理领域在预测期内复合年增长率最高。这是因为对方便且患者友好的替代品的需求正在促进市场扩张。此外，创新配方和技术的发展提高了经皮给药的有效性，使其成为疼痛管理的有吸引力的选择。随着医疗保健提供者优先考虑更安全、更容易获得的疼痛治疗，经皮给药系统市场预计将持续成长。

比最大的地区

由于有利的报销方案和政府组织意识的提高等因素，预计亚太地区将在预测期内占据最大的市场占有率，从而促进该地区经皮给药系统市场的成长。随着医疗保健结构的发展足以支付公民的医疗费用，越来越多的人选择在该地区寻求治疗。预计这将进一步推动预测期内的市场成长。

复合年增长率最高的地区：

由于医疗基础设施、技术进步以及对製药业研发的日益关注，预计北美在预测期内将出现最高的复合年增长率。此外，该国慢性病的高盛行率和人口老化正在增加对经皮吸收贴片创新给药系统的需求。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球经皮给药系统市场：依产品类型

  • 经皮吸收贴片
  • 凝胶
  • 喷
  • 微型针
  • 离子导入系统
  • 其他产品类型

第六章全球经皮给药系统市场：依组成部分

  • 控制膜
  • 药物储存
  • 微储库阵列
  • 黏剂系统
  • 渗透促进剂
  • 载体系统

第七章全球经皮给药系统市场：依技术分类

  • 矩阵系统
  • 电穿孔
  • 超音波介绍
  • 喷射注射器
  • 微米和奈米技术

第八章全球经皮给药系统市场：依应用分类

  • 疼痛管理
  • 荷尔蒙补充疗法（HRT）
  • 心血管疾病
  • 中枢神经系统疾病
  • 禁止抽烟
  • 糖尿病
  • 其他用途

第九章全球经皮给药系统市场：依最终使用者分类

  • 医院和诊所
  • 门诊手术中心
  • 研究和学术机构
  • 製药公司
  • 兽医护理
  • 其他最终用户

第十章全球经皮给药系统市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司简介

  • Johnson & Johnson
  • Novartis AG
  • Boehringer Ingelheim GmbH
  • Mylan Pharmaceuticals, Inc.
  • 3M Company
  • Noven Pharmaceuticals, Inc.
  • Grunenthal
  • 4P Therapeutics, LLC
  • AbbVie
  • Hisamitsu Pharmaceutical co. Inc
  • Endo International
  • Purdue Pharma
  • GlaxoSmithKline
  • UCB
  • Viatris Inc.
  • Styker
  • Grifols
  • Amgen
  • Lubrizol Corporation
  • AdhexPharma
Product Code: SMRC25411

According to Stratistics MRC, the Global Transdermal Drug Delivery Systems Market is accounted for $66.2 billion in 2023 and is expected to reach $164.6 billion by 2030 growing at a CAGR of 13.9% during the forecast period. Transdermal drug delivery systems administer medications through the skin, providing a non-invasive and controlled approach. They utilize patches containing drug formulations, allowing gradual absorption into the bloodstream. The skin's outer layer, the stratum corneum, acts as a barrier, regulating drug release. This method minimizes side effects, enhances patient compliance, and maintains steady drug levels.

According to the World Federation of Neurology's 2023 report, neurological disorders currently rank as the second highest cause of death and the primary cause of disability worldwide. A Global Burden of Disease (GBD) study forecasts a doubling of individuals living with brain diseases by 2050.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

As diabetes, cardiovascular conditions, and chronic pain become more widespread, TDDS emerges as a preferred solution due to its convenience, sustained drug release, and improved patient compliance. The rising need for long-term medication adherence aligns with TDDS's ability to offer non-invasive, user-friendly administration. This trend propels market growth, encouraging pharmaceutical innovation and expanding the scope of transdermal patches into diverse therapeutic areas, creating a dynamic landscape for effective chronic disease management.

Restraint:

Limited range of suitable drugs

The inherent characteristics of certain medications, such as molecular size, lipophilicity, and charge, restrict their effective transdermal delivery. This limitation narrows the scope of applications, hindering the market's growth potential. Pharmaceutical advancements are essential to expand the repertoire of drugs compatible with TDDS. Overcoming this constraint is crucial for realizing the full potential of transdermal delivery in offering non-invasive and patient-friendly alternatives, especially for medications crucial in managing chronic conditions.

Opportunity:

Increasing demand for non-invasive drug delivery

As patients seek convenient, painless alternatives, transdermal patches offer an attractive solution by delivering medications through the skin. This approach enhances patient compliance and comfort, particularly for chronic conditions requiring prolonged treatment. The growing preference for non-invasive options, driven by the desire to reduce needle-related anxieties and improve overall treatment experience, positions transdermal drug delivery as a key player in meeting healthcare demands.

Threat:

High development and regulatory costs

The complex and stringent regulatory requirements, coupled with extensive research and development expenses, create financial barriers for companies. These costs may deter investment and innovation, limiting the introduction of novel transdermal formulations. Consequently, the market may experience slower growth and reduced accessibility to advanced transdermal technologies.

Covid-19 Impact

Supply chain disruptions, reduced healthcare visits, and diverted resources towards pandemic management have affected market growth. However, the demand for non-invasive drug delivery methods and the focus on home-based treatments have increased interest in transdermal systems. The industry is adapting to address challenges, such as remote patient monitoring and enhancing the efficacy of transdermal drug delivery. The pandemic has accelerated innovation and research in this sector, fostering resilience and potential future growth in the context of evolving healthcare needs and preferences.

The transdermal patches segment is expected to be the largest during the forecast period

The transdermal patches segment is estimated to have a lucrative growth, due to the ease of use, reduced side effects, and improved compliance associated with patches have driven market growth. They offer advantages like controlled drug release, sustained therapeutic levels, and minimized fluctuations. This has led to increased acceptance among patients and healthcare providers. Moreover the Transdermal Drug Delivery Systems market continues to expand as technological advancements address challenges and pave the way for innovative applications, demonstrating a shift towards more efficient, patient-centric drug delivery solutions.

The pain management segment is expected to have the highest CAGR during the forecast period

The pain management segment is anticipated to witness the highest CAGR growth during the forecast period, owing to the demand for a convenient and patient-friendly alternative contributes to the market expansion. Additionally, the development of innovative formulations and technologies enhances the efficacy of transdermal drug delivery, making it an attractive option for pain management. As healthcare providers prioritize safer and more accessible pain therapies, the market for transdermal drug delivery systems is poised to experience continued growth.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the factors such as favourable reimbursement scenarios and rising awareness by government organizations contribute to the region's transdermal drug delivery system market growth. A well-developed healthcare structure covering the citizens' healthcare costs promotes more people opting for treatment in the region. This is expected further to boost the market growth over the forecast period.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, due to its access to healthcare infrastructure, technological advancements, and a substantial focus on research and development within the pharmaceutical industry. Additionally, a higher prevalence of chronic diseases and an aging population in the country have fueled the demand for innovative drug delivery systems like transdermal patches.

Key players in the market

Some of the key players in the Transdermal Drug Delivery Systems Market include Johnson & Johnson, Novartis AG, Boehringer Ingelheim GmbH, Mylan Pharmaceuticals, Inc., 3M Company, Noven Pharmaceuticals, Inc., Grunenthal, 4P Therapeutics, LLC, AbbVie, Hisamitsu Pharmaceutical co. Inc, Endo International, Purdue Pharma, GlaxoSmithKline, UCB , Viatris Inc., Styker, Grifols, Amgen, Lubrizol Corporation and AdhexPharma

Key Developments:

In February 2024, Novartis to strengthen oncology pipeline with agreement to acquire MorphoSys AG for EUR 68 per share or an aggregate of EUR 2.7bn in cash. The acquisition, which is subject to customary closing conditions, including a minimum acceptance threshold of 65% of outstanding shares tendered in the takeover offer and regulatory approvals

In January 2024, Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer. In addition, Ambrx's pipeline and ADC platform present exciting future opportunities to deliver enhanced, precision biologics as transform the treatment of cancer and improve patients' lives.

In January 2024, CERENOVUS Launches Next Generation Catheter for Revascularization of Patients with Acute Ischemic Stroke and is optimized for effective direct aspiration and for the delivery of compatible stent retrievers,iii including the EMBOTRAP(TM) III Revascularization Device, into the neurovasculature.

Product Types Covered:

  • Transdermal Patches
  • Gels
  • Sprays
  • Microneedles
  • Iontophoresis Systems
  • Other Product Types

Components Covered:

  • Controlled Membrane
  • Drug Reservoir
  • Micro-Reservoir Arrays
  • Adhesive System
  • Permeation Enhancers
  • Carrier Systems

Technologies Covered:

  • Matrix Systems
  • Electroporation
  • Sonophoresis
  • Jet Injectors
  • Micro- and Nano-Technology

Applications Covered:

  • Pain Management
  • Hormone Replacement Therapy (HRT)
  • Cardiovascular Disorders
  • Central Nervous System Disorders
  • Smoking Cessation
  • Diabetes
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Research & Academic Institutes
  • Pharmaceutical Companies
  • Veterinary Care
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Transdermal Drug Delivery Systems Market, By Product Type

  • 5.1 Introduction
  • 5.2 Transdermal Patches
  • 5.3 Gels
  • 5.4 Sprays
  • 5.5 Microneedles
  • 5.6 Iontophoresis Systems
  • 5.7 Other Product Types

6 Global Transdermal Drug Delivery Systems Market, By Component

  • 6.1 Introduction
  • 6.2 Controlled Membrane
  • 6.3 Drug Reservoir
  • 6.4 Micro-Reservoir Arrays
  • 6.5 Adhesive System
  • 6.6 Permeation Enhancers
  • 6.7 Carrier Systems

7 Global Transdermal Drug Delivery Systems Market, By Technology

  • 7.1 Introduction
  • 7.2 Matrix Systems
  • 7.3 Electroporation
  • 7.4 Sonophoresis
  • 7.5 Jet Injectors
  • 7.6 Micro- and Nano-Technology

8 Global Transdermal Drug Delivery Systems Market, By Application

  • 8.1 Introduction
  • 8.2 Pain Management
  • 8.3 Hormone Replacement Therapy (HRT)
  • 8.4 Cardiovascular Disorders
  • 8.5 Central Nervous System Disorders
  • 8.6 Smoking Cessation
  • 8.7 Diabetes
  • 8.8 Other Applications

9 Global Transdermal Drug Delivery Systems Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Clinics
  • 9.3 Ambulatory Surgical Centers
  • 9.4 Research & Academic Institutes
  • 9.5 Pharmaceutical Companies
  • 9.6 Veterinary Care
  • 9.7 Other End Users

10 Global Transdermal Drug Delivery Systems Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Johnson & Johnson
  • 12.2 Novartis AG
  • 12.3 Boehringer Ingelheim GmbH
  • 12.4 Mylan Pharmaceuticals, Inc.
  • 12.5 3M Company
  • 12.6 Noven Pharmaceuticals, Inc.
  • 12.7 Grunenthal
  • 12.8 4P Therapeutics, LLC
  • 12.9 AbbVie
  • 12.10 Hisamitsu Pharmaceutical co. Inc
  • 12.11 Endo International
  • 12.12 Purdue Pharma
  • 12.13 GlaxoSmithKline
  • 12.14 UCB
  • 12.15 Viatris Inc.
  • 12.16 Styker
  • 12.17 Grifols
  • 12.18 Amgen
  • 12.19 Lubrizol Corporation
  • 12.20 AdhexPharma

List of Tables

  • Table 1 Global Transdermal Drug Delivery Systems Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Transdermal Drug Delivery Systems Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Transdermal Drug Delivery Systems Market Outlook, By Transdermal Patches (2021-2030) ($MN)
  • Table 4 Global Transdermal Drug Delivery Systems Market Outlook, By Gels (2021-2030) ($MN)
  • Table 5 Global Transdermal Drug Delivery Systems Market Outlook, By Sprays (2021-2030) ($MN)
  • Table 6 Global Transdermal Drug Delivery Systems Market Outlook, By Microneedles (2021-2030) ($MN)
  • Table 7 Global Transdermal Drug Delivery Systems Market Outlook, By Iontophoresis Systems (2021-2030) ($MN)
  • Table 8 Global Transdermal Drug Delivery Systems Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 9 Global Transdermal Drug Delivery Systems Market Outlook, By Component (2021-2030) ($MN)
  • Table 10 Global Transdermal Drug Delivery Systems Market Outlook, By Controlled Membrane (2021-2030) ($MN)
  • Table 11 Global Transdermal Drug Delivery Systems Market Outlook, By Drug Reservoir (2021-2030) ($MN)
  • Table 12 Global Transdermal Drug Delivery Systems Market Outlook, By Micro-Reservoir Arrays (2021-2030) ($MN)
  • Table 13 Global Transdermal Drug Delivery Systems Market Outlook, By Adhesive System (2021-2030) ($MN)
  • Table 14 Global Transdermal Drug Delivery Systems Market Outlook, By Permeation Enhancers (2021-2030) ($MN)
  • Table 15 Global Transdermal Drug Delivery Systems Market Outlook, By Carrier Systems (2021-2030) ($MN)
  • Table 16 Global Transdermal Drug Delivery Systems Market Outlook, By Technology (2021-2030) ($MN)
  • Table 17 Global Transdermal Drug Delivery Systems Market Outlook, By Matrix Systems (2021-2030) ($MN)
  • Table 18 Global Transdermal Drug Delivery Systems Market Outlook, By Electroporation (2021-2030) ($MN)
  • Table 19 Global Transdermal Drug Delivery Systems Market Outlook, By Sonophoresis (2021-2030) ($MN)
  • Table 20 Global Transdermal Drug Delivery Systems Market Outlook, By Jet Injectors (2021-2030) ($MN)
  • Table 21 Global Transdermal Drug Delivery Systems Market Outlook, By Micro- and Nano-Technology (2021-2030) ($MN)
  • Table 22 Global Transdermal Drug Delivery Systems Market Outlook, By Application (2021-2030) ($MN)
  • Table 23 Global Transdermal Drug Delivery Systems Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 24 Global Transdermal Drug Delivery Systems Market Outlook, By Hormone Replacement Therapy (HRT) (2021-2030) ($MN)
  • Table 25 Global Transdermal Drug Delivery Systems Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
  • Table 26 Global Transdermal Drug Delivery Systems Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
  • Table 27 Global Transdermal Drug Delivery Systems Market Outlook, By Smoking Cessation (2021-2030) ($MN)
  • Table 28 Global Transdermal Drug Delivery Systems Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 29 Global Transdermal Drug Delivery Systems Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 30 Global Transdermal Drug Delivery Systems Market Outlook, By End User (2021-2030) ($MN)
  • Table 31 Global Transdermal Drug Delivery Systems Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 32 Global Transdermal Drug Delivery Systems Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 33 Global Transdermal Drug Delivery Systems Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
  • Table 34 Global Transdermal Drug Delivery Systems Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 35 Global Transdermal Drug Delivery Systems Market Outlook, By Veterinary Care (2021-2030) ($MN)
  • Table 36 Global Transdermal Drug Delivery Systems Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.